Citius Pharmaceuticals, Inc. Reports Fiscal Third Quarter 2026 Financial Results and Provides Business Update

EarningsLYMPHIRNeutral

AI Analysis

Summary

Citius Pharmaceuticals reported $7.1 million in revenue from LYMPHIR commercial sales for the first nine months of fiscal 2026, with $17 million in cash on hand and expanded commercial operations nationwide.

Financial Highlights

Revenue

$7.1 million for first nine months of fiscal 2026

Importance:2/10

Sentiment:

0.20

earningscommercial salesLYMPHIRbusiness update

Related Companies

$MDCE $TRAX

Read the original article

Published by PR Newswire Biotech on August 14, 2026 8:30 PM

Read Original